Preoperative immunochemotherapy with PSK for Stage II/III gastric and colorectal cancer to evaluate anti-tumor effect and transition of PSKinto tumor
Not Applicable
- Conditions
- Gastric and colorectal cancer with clinical stage II/III
- Registration Number
- JPRN-UMIN000005286
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with active gastro-intestinal bleeding 2. Patients with massive ascites 3. Patients with active infection desease and ileus 4. Pregnant women 5. Patients with uncontrolled diabetes 6. Patients with ischemic heart desease 7. Patients with uncontrolled psychiatric disorder 8. Required administration of continual steroids 9. Histry of severe allergic desease 10. Pateints assesed inadequate case by principal investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To examine transition of PSK and induce infiltration of cytotoxic T lymphocytes into primary tumor
- Secondary Outcome Measures
Name Time Method